blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2245183

EP2245183 - PSMB10: A DIAGNOSIS MARKER AND THERAPEUTIC TARGET OF CHRONIC REJECTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.02.2013
Database last updated on 03.10.2024
Most recent event   Tooltip01.02.2013Application deemed to be withdrawnpublished on 06.03.2013  [2013/10]
Applicant(s)For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101, rue de Tolbiac
75013 Paris / FR
For all designated states
TC LAND Expression
21, rue de la Noue Bras de Fer Bio Ouest Ile de Nantes
44200 Nantes / FR
[N/P]
Former [2010/44]For all designated states
INSERM - Institut National de la Santé et de la Recherche Médicale
101 rue de Tolbiac
75013 Paris / FR
For all designated states
TC LAND Expression
21, rue de la Noue Bras de Fer Bio Ouest Ile de Nantes
44200 Nantes / FR
Inventor(s)01 / BROUARD, Sophie
Les Vaux
F-44240 Suce sur Erdre / FR
02 / GIRAL, Magali
La Vincendière
F-44470 Carquefou / FR
03 / SOULILLOU, Jean-Paul
32 ter rue Abbaye
F-44000 Nantes / FR
04 / JOVANOVIC, Vojislav
36 rue des Landes
F-44000 Nantes / FR
05 / ASHTON-CHESS, Joanna
59 rue Fontaine de Barbin
F-44000 Nantes / FR
 [2010/44]
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2012/49]
Former [2012/30]Faivre Petit, Frédérique, et al
Cabinet Regimbeau 20, rue de Chazelles
75847 Paris Cedex 17 / FR
Former [2010/44]Warcoin, Jacques
Cabinet Régimbeau 20, rue de Chazelles
75847 Paris Cedex 17 / FR
Application number, filing date09711003.510.02.2009
[2010/44]
WO2009EP51511
Priority number, dateEP2008030008411.02.2008         Original published format: EP 08300084
[2010/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009101083
Date:20.08.2009
Language:EN
[2009/34]
Type: A1 Application with search report 
No.:EP2245183
Date:03.11.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 20.08.2009 takes the place of the publication of the European patent application.
[2010/44]
Search report(s)International search report - published on:EP20.08.2009
ClassificationIPC:C12Q1/68
[2010/44]
CPC:
C12Q1/6883 (EP,US); C12Q1/6881 (EP,US); C10N2010/02 (EP,US);
C12Q2600/158 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/44]
TitleGerman:PSMB10: EIN DIAGNOSEMARKER UND THERAPEUTISCHES ZIEL FÜR CHRONISCHE ABSTOSSUNG[2010/44]
English:PSMB10: A DIAGNOSIS MARKER AND THERAPEUTIC TARGET OF CHRONIC REJECTION[2010/44]
French:PSMB10: MARQUEUR DE DIAGNOSTIC ET CIBLE THÉRAPEUTIQUE DE REJET CHRONIQUE[2010/44]
Entry into regional phase31.08.2010National basic fee paid 
31.08.2010Designation fee(s) paid 
31.08.2010Examination fee paid 
Examination procedure31.08.2010Examination requested  [2010/44]
28.10.2010Amendment by applicant (claims and/or description)
25.02.2011Despatch of a communication from the examining division (Time limit: M04)
06.06.2011Reply to a communication from the examining division
03.09.2012Application deemed to be withdrawn, date of legal effect  [2013/10]
10.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/10]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.02.2011
Fees paidRenewal fee
29.04.2011Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
28.02.201103   M06   Fee paid on   29.04.2011
29.02.201204   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - DONAUER J ET AL, "EXPRESSION PROFILING ON CHRONICALLY REJECTED TRANSPLANT KIDNEYS", TRANSPLANTATION, WILLIAMS AND WILKINS, BALTIMORE, MD, US, (20030815), vol. 76, no. 3, ISSN 0041-1337, pages 539 - 547, XP009045200 [X] 1-4,8,9,11,12 * the whole document * * table 2 *

DOI:   http://dx.doi.org/10.1097/01.TP.0000079459.89608.B7
 [X]  - MATEOS-MAZON JUAN ET AL, "Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation", HAEMATOLOGICA, FONDAZIONE FERRATA STORTI, ROME, IT, (20070901), vol. 92, no. 9, ISSN 0390-6078, pages 1295 - 1296, XP009108243 [X] 13,14 * abstract * * the whole document *

DOI:   http://dx.doi.org/10.3324/haematol.10820
 [X]  - ZWEEGMAN S ET AL, "Immune-modulatory effects of bortezomib in GVHD", LEUKEMIA AND LYMPHOMA, HARWOOD ACADEMIC PUBLISHERS, CHUR, CH, (20070501), vol. 48, no. 5, ISSN 1042-8194, pages 853 - 854, XP009108242 [X] 13,14 * the whole document *

DOI:   http://dx.doi.org/10.1080/10428190701297394
 [X]  - TODISCO E ET AL, "Inhibition of chronic graft-vs-host disease with retention of anti-myeloma effects by the proteasome inhibitor bortezomib", LEUKEMIA AND LYMPHOMA, HARWOOD ACADEMIC PUBLISHERS, CHUR, CH, (20070501), vol. 48, no. 5, ISSN 1042-8194, pages 1015 - 1018, XP009108241 [X] 13,14 * the whole document *

DOI:   http://dx.doi.org/10.1080/10428190701253843
Examination   - FLECHNER S M ET AL, "Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes", AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL MUNKSGAARD, DK, (20040901), vol. 4, no. 9, doi:DOI:10.1111/J.1600-6143.2004.00526.X, ISSN 1600-6135, pages 1475 - 1489, XP002322115

DOI:   http://dx.doi.org/10.1111/j.1600-6143.2004.00526.x
by applicantWO2004071382
 WO2006017981
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.